Senior Scientist
Sangamo Therapeutics
Brisbane, California
Dr. Yonghua Pan is a Senior Scientist in the Biomarker and BioAnalytical Sciences group at Sangamo Therapeutics. She leads the bioanalytical strategies to support preclinical and clinical development of gene and cell therapy programs and contributes to cross-functional project teams. She also leads an assay team focusing on biomarker and immunogenicity assay development. Dr. Pan previously held positions at Coyote Pharmaceuticals where she contributed to the development of small molecule therapeutics for neurodegenerative diseases, and at Dynavax Technologies focusing on the development of biopotency assays. Dr. Pan received her Ph.D. in Molecular Cell Biology from Washington University in St. Louis, MO. She then conducted a postdoctoral training at UCSF prior to joining the industry.
Disclosure information not submitted.
Wednesday, October 19, 2022
9:30 AM – 10:00 AM ET